DK1028744T3 - Neuronale anvendelser af BMP-11 - Google Patents

Neuronale anvendelser af BMP-11

Info

Publication number
DK1028744T3
DK1028744T3 DK98957711T DK98957711T DK1028744T3 DK 1028744 T3 DK1028744 T3 DK 1028744T3 DK 98957711 T DK98957711 T DK 98957711T DK 98957711 T DK98957711 T DK 98957711T DK 1028744 T3 DK1028744 T3 DK 1028744T3
Authority
DK
Denmark
Prior art keywords
bmp
proteins
useful
disclosed
neuronal
Prior art date
Application number
DK98957711T
Other languages
English (en)
Inventor
Anthony J Celeste
John M Wozney
Scott R Thies
Original Assignee
Inst Genetics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Genetics Llc filed Critical Inst Genetics Llc
Application granted granted Critical
Publication of DK1028744T3 publication Critical patent/DK1028744T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0619—Neurons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DK98957711T 1997-11-07 1998-11-06 Neuronale anvendelser af BMP-11 DK1028744T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96629797A 1997-11-07 1997-11-07
PCT/US1998/023827 WO1999024058A2 (en) 1997-11-07 1998-11-06 Neuronal uses of bmp-11

Publications (1)

Publication Number Publication Date
DK1028744T3 true DK1028744T3 (da) 2004-06-21

Family

ID=25511184

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98957711T DK1028744T3 (da) 1997-11-07 1998-11-06 Neuronale anvendelser af BMP-11

Country Status (10)

Country Link
EP (1) EP1028744B1 (da)
JP (1) JP2001522810A (da)
AT (1) ATE259652T1 (da)
AU (2) AU1276399A (da)
CA (1) CA2309538A1 (da)
DE (1) DE69821793T2 (da)
DK (1) DK1028744T3 (da)
ES (1) ES2213927T3 (da)
PT (1) PT1028744E (da)
WO (2) WO1999024057A2 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030104977A1 (en) * 2000-03-31 2003-06-05 Ugo Ripamonti Methods for inducing angiogenesis using morphogenic proteins and stimulatory factors
TW200526779A (en) * 2001-02-08 2005-08-16 Wyeth Corp Modified and stabilized GDF propeptides and uses thereof
WO2003004527A2 (en) * 2001-07-06 2003-01-16 Nsgene A/S Novel neurotrophic factors
US7320789B2 (en) 2001-09-26 2008-01-22 Wyeth Antibody inhibitors of GDF-8 and uses thereof
KR20040094709A (ko) 2002-02-21 2004-11-10 와이어쓰 폴리스타틴 도메인을 포함하는 단백질
PL374966A1 (en) 2002-02-21 2005-11-14 Wyeth Follistatin domain containing proteins
US7261893B2 (en) 2002-10-22 2007-08-28 Wyeth Neutralizing antibodies against GDF-8 and uses therefor
WO2004078211A1 (ja) * 2003-03-04 2004-09-16 Tanabe Seiyaku Co., Ltd. 粉末経鼻投与製剤
CN1829532A (zh) 2003-06-02 2006-09-06 惠氏公司 肌肉抑制素（gdf8）抑制剂和皮质类固醇联合用于治疗神经肌肉紊乱的用途
KR101135220B1 (ko) 2005-10-06 2012-04-24 일라이 릴리 앤드 캄파니 항-마이오스타틴 항체
UA92504C2 (en) 2005-10-12 2010-11-10 Эли Лилли Энд Компани Anti-myostatin monoclonal antibody
WO2008030706A2 (en) 2006-09-05 2008-03-13 Eli Lilly And Company Anti-myostatin antibodies
EP4140497A1 (en) 2013-04-08 2023-03-01 President and Fellows of Harvard College Compositions for rejuvenating skeletal muscle stem cells
US20160220640A1 (en) * 2013-06-11 2016-08-04 The Brigham And Women's Hospital, Inc. Methods and compositions for increasing neurogenesis and angiogenesis
WO2015070076A2 (en) * 2013-11-08 2015-05-14 President And Fellows Of Harvard College Methods and compositions for rejuvenating neuromuscular junctions
JP6948331B2 (ja) 2016-01-06 2021-10-13 プレジデント アンド フェローズ オブ ハーバード カレッジ Ｇｄｆ１１での処置は、体重増加を防止し、耐糖能を改善し、そして脂肪肝を低減する
WO2019144053A1 (en) * 2018-01-19 2019-07-25 President And Fellows Of Harward College Gdf11 variants and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2272959A1 (en) * 1993-05-12 2011-01-12 Genetics Institute, LLC BMP-11 compositions
SE9302550D0 (sv) * 1993-07-30 1993-07-30 Ernst Hoerlin Powder inhaler
KR100328752B1 (ko) * 1993-08-26 2002-09-26 더 보오드 오브 트러스티스 오브 더 유니버시티 오브 일리노이즈 인간골형태발생단백질을사용한신경재생법
WO1996001845A1 (en) * 1994-07-08 1996-01-25 The Johns Hopkins University School Of Medicine Growth differentiation factor-11

Also Published As

Publication number Publication date
WO1999024057A2 (en) 1999-05-20
JP2001522810A (ja) 2001-11-20
DE69821793T2 (de) 2004-12-30
CA2309538A1 (en) 1999-05-20
ES2213927T3 (es) 2004-09-01
AU761940B2 (en) 2003-06-12
WO1999024058A3 (en) 1999-08-19
ATE259652T1 (de) 2004-03-15
AU1390099A (en) 1999-05-31
EP1028744A2 (en) 2000-08-23
WO1999024058A2 (en) 1999-05-20
DE69821793D1 (de) 2004-03-25
EP1028744B1 (en) 2004-02-18
PT1028744E (pt) 2004-06-30
AU1276399A (en) 1999-05-31

Similar Documents

Publication Publication Date Title
PT698094E (pt) Composicoes de bmp-11
DK1028744T3 (da) Neuronale anvendelser af BMP-11
DE69433742D1 (de) Bmp-10 zusammensetzungen
DE69823046D1 (de) Praktische in vitro sialylierung von rekombinanten glykpproteinen
DK0429570T3 (da) Osteoinducerende præparater
ATE328896T1 (de) Faktor viii vom schwein und hybriden
ATE223486T1 (de) Bmp-9 zusammensetzungen
ATE256740T1 (de) Menschliches sdf-5 protein und diesbezügliche zusammensetzungen
ATE112317T1 (de) Bcrf1-proteine als inhibitoren von interferon- g(g).
ES2170251T3 (es) (s)-hidroxinitriloliasa de hevea brasiliensis.
GR3033698T3 (en) Use of a hymenoptera venom for the manufacture of a medicament for treating dna virus infections.
ATE349521T1 (de) Mit cd40 und traf interagierende proteine
DK0925333T3 (da) Froststabilisering af vandige overtræksmidler med frostbeskyttelsesproteiner
ITMI931034A1 (it) Processo per la preparazione di proteine inibenti i ribosomi